Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion type Assertion NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_head.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion description "[Amplification of the CBFbeta/MYH11 fusion transcript by a qualitative reverse transcription-polymerase chain reaction (RT-PCR) has been used to detect minimal residual disease (MRD) and assess the risk for disease relapse in inv(16)(p13q22) acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion evidence source_evidence_literature NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion SIO_000772 11455976 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion wasDerivedFrom befree-2016 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.
- NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_assertion wasGeneratedBy ECO_0000203 NP324119.RAa0-wWPgvLMNGVlNR9O-euEktDQVqylc69UiXrFFXdrA130_provenance.